Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$13.35−0.37 (-2.70%)
Close on Nov 12, 2026Market cap $2.01BP/E –Yield 3.84%
Chemours cash
Cash and short-term investments held at the end of each period.
Chemours's cash was $698.00M at Sep 30, 2026. For fiscal 2025 it was $670.00M, down 12.2% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is $1.56B in fiscal 2017.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $670.00M | -12.2% |
| FY2024 | Dec 31, 2024 | $763.00M | -36.6% |
| FY2023 | Dec 31, 2023 | $1.20B | -7.7% |
| FY2022 | Dec 31, 2022 | $1.30B | -15.9% |
| FY2021 | Dec 31, 2021 | $1.55B | +40.4% |
| FY2020 | Dec 31, 2020 | $1.11B | +17.2% |
| FY2019 | Dec 31, 2019 | $943.00M | -21.5% |
| FY2018 | Dec 31, 2018 | $1.20B | -22.8% |
| FY2017 | Dec 31, 2017 | $1.56B | +72.5% |
| FY2016 | Dec 31, 2016 | $902.00M | +146.4% |
| FY2015 | Dec 31, 2015 | $366.00M | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $698.00M | +5.0% |
| Q2 FY2026 | Jun 30, 2026 | $671.00M | +21.3% |
| Q1 FY2026 | Mar 31, 2026 | $563.00M | +9.5% |
| Q4 FY2025 | Dec 31, 2025 | $670.00M | -12.2% |
| Q3 FY2025 | Sep 30, 2025 | $665.00M | -0.2% |
| Q2 FY2025 | Jun 30, 2025 | $553.00M | -10.7% |
| Q1 FY2025 | Mar 31, 2025 | $514.00M | -62.0% |
| Q4 FY2024 | Dec 31, 2024 | $763.00M | -36.6% |
| Q3 FY2024 | Sep 30, 2024 | $666.00M | -54.0% |
| Q2 FY2024 | Jun 30, 2024 | $619.00M | -34.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.35B | +32.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.20B | -7.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.45B | +5.8% |
| Q2 FY2023 | Jun 30, 2023 | $945.00M | -29.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.02B | -18.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.30B | -15.9% |
| Q3 FY2022 | Sep 30, 2022 | $1.37B | +21.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.35B | +18.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.25B | +23.5% |
| Q4 FY2021 | Dec 31, 2021 | $1.55B | +40.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.13B | +18.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.14B | +10.5% |
| Q1 FY2021 | Mar 31, 2021 | $1.01B | +41.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.11B | +17.2% |
| Q3 FY2020 | Sep 30, 2020 | $956.00M | +37.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.03B | +63.7% |
| Q1 FY2020 | Mar 31, 2020 | $714.00M | +2.4% |
| Q4 FY2019 | Dec 31, 2019 | $943.00M | -21.5% |
| Q3 FY2019 | Sep 30, 2019 | $694.00M | -45.6% |
| Q2 FY2019 | Jun 30, 2019 | $630.00M | -48.2% |
| Q1 FY2019 | Mar 31, 2019 | $697.00M | -51.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.20B | -22.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.28B | -16.9% |
| Q2 FY2018 | Jun 30, 2018 | $1.22B | -20.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.43B | +59.7% |
| Q4 FY2017 | Dec 31, 2017 | $1.56B | +72.5% |
| Q3 FY2017 | Sep 30, 2017 | $1.54B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.53B | – |
| Q1 FY2017 | Mar 31, 2017 | $898.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $902.00M | – |
See a number that looks wrong?